Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7004 |
filingDate |
1987-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1993-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
1993-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0249008-B1 |
titleOfInvention |
Use of specific monosaccharides for the preparation of a medicament for the prevention of metastases of malignic tumours |
abstract |
The monosaccharides which are specific to organ cell lectins and/or glycoconjugates which contain, preferably terminally, these monosaccharides, in particular beta -D-galactose and/or glycoconjugates containing terminal beta -D-galactose, are used. |
priorityDate |
1986-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |